Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | MGX | Series A-1 Convertible Preferred Stock | Feb 8, 2024 | Common Stock | 1.77M | Direct | F1, F2 | |||||||
holding | MGX | Series A-4 Convertible Preferred Stock | Feb 8, 2024 | Common Stock | 1.18M | Direct | F2, F3 | |||||||
holding | MGX | Series B Convertible Preferred Stock | Feb 8, 2024 | Common Stock | 590K | Direct | F2, F4 | |||||||
holding | MGX | Series B-1 Convertible Preferred Stock | Feb 8, 2024 | Common Stock | 510K | Direct | F2, F5 |
Id | Content |
---|---|
F1 | Each share of Series A-1 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's Initial Public Offering ("IPO"). Each share of Series A-1 Convertible Preferred Stock has no expiration date. |
F2 | The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is controlled by Bayer US Holding LP ("BUSH LP"), a Delaware limited partnership. Bayer World Investments B.V. ("BWI"), a Dutch private limited company, is the general partner of BUSH LP. BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC. |
F3 | Each share of Series A-4 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series A-4 Convertible Preferred Stock has no expiration date. |
F4 | Each share of Series B Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series B Convertible Preferred Stock has no expiration date. |
F5 | Each share of Series B-1 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series B-1 Convertible Preferred Stock has no expiration date. |